Simulated Driving and Attention of Repeat Users of MDMA and THC Compared with THC Users and Non-Drug-Using Controls

The aim of the study is to assess if cognitive impairments in abstinent users of methylenedioxymethamphetamine (MDMA) are due to repeated use of MDMA or concurrent drugs of abuse and how these impairments interfere with key activities of daily life such as automobile driving. Simulated driving performance and attention of 12 users of MDMA and marijuana [tetrahydrocannabinol (THC)] (MDMA/THC), 15 THC users, and 15 non-drug-using, age-matched controls were compared. THC users' mean speed reduction in response to passing a car parked on the shoulder of the road was 7 mph (11.3 km/h) less than that of controls. Compared with non-drug-using controls, the MDMA/THC users were less able to mitigate the effects of an illegal intersection incursion by another vehicle and entered the collision at a higher speed (42 versus 26 mph). In real life, this 16-mph (26-km/h) difference would increase the likelihood of injuring parties in both colliding vehicles. Processing speed and attention did not differ between groups; t...

[1]  A. García-Osta,et al.  Differential Regulation by Methylenedioxymethamphetamine of 5‐Hydroxytryptamine1A Receptor Density and mRNA Expression in Rat Hippocampus, Frontal Cortex, and Brainstem: The Role of Corticosteroids , 1997, Journal of neurochemistry.

[2]  E. Gouzoulis-Mayfrank,et al.  Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) , 2000, Journal of neurology, neurosurgery, and psychiatry.

[3]  A. Lees,et al.  Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits , 1998, Journal of psychopharmacology.

[4]  G. Guyatt,et al.  The independent contribution of driver, crash, and vehicle characteristics to driver fatalities. , 2002, Accident; analysis and prevention.

[5]  J. Robinson,et al.  Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? , 2001, Psychopharmacology.

[6]  J. Rodgers,et al.  Cognitive performance amongst recreational users of "ecstasy , 2000, Psychopharmacology.

[7]  Y. Shaham,et al.  Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans , 1994, Neuropsychopharmacology.

[8]  M. Rizzo,et al.  Motion and shape perception in cerebral akinetopsia. , 1995, Brain : a journal of neurology.

[9]  U. McCann,et al.  Severe Dopaminergic Neurotoxicity in Primates After a Common Recreational Dose Regimen of MDMA ("Ecstasy") , 2002, Science.

[10]  M. Sloane,et al.  Visual processing impairment and risk of motor vehicle crash among older adults. , 1998, JAMA.

[11]  A. Young,et al.  A study of the effect of a single neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy") on the subsequent long-term behaviour of rats in the plus maze and open field , 2002, Psychopharmacology.

[12]  P C Dischinger,et al.  Effect of change in velocity on the development of medical complications in patients with multisystem trauma sustained in vehicular crashes. , 1998, Accident; analysis and prevention.

[13]  L. Chait,et al.  Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance , 1994, Psychopharmacology.

[14]  D Mahalel,et al.  Driver's decision process on termination of the green light. , 1985, Accident; analysis and prevention.

[15]  J. Krystal,et al.  Chronic 3,4-methylenedioxymethamphetamine (MDMA) use: effects on mood and neuropsychological function? , 1992, The American journal of drug and alcohol abuse.

[16]  S. Vecera,et al.  Psychoanatomical substrates of Bálint's syndrome , 2002, Journal of neurology, neurosurgery, and psychiatry.

[17]  A. Bechara,et al.  Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls , 2006, Journal of psychopharmacology.

[18]  J. Alvarez,et al.  Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression. , 2001, Life sciences.

[19]  M. Morgan.  Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity , 1998, Neuropsychopharmacology.

[20]  I. Deary,et al.  The NART as an index of prior intellectual functioning: a retrospective validity study covering a 66-year interval , 2001, Psychological Medicine.

[21]  Rodney J. Croft,et al.  The relative contributions of ecstasy and cannabis to cognitive impairment , 2001, Psychopharmacology.

[22]  M. Wheaton,et al.  THE EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE (MDMA, “ECSTASY”) ON MONOAMINERGIC NEUROTRANSMISSION IN THE CENTRAL NERVOUS SYSTEM , 1996, Progress in Neurobiology.

[23]  M. Colado,et al.  Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration , 1999, Psychopharmacology.

[24]  C. Owsley,et al.  Vision and Driving in the Elderly , 1994, Optometry and vision science : official publication of the American Academy of Optometry.

[25]  M Mäntyjärvi,et al.  Normal values for the Pelli‐Robson contrast sensitivity test , 2001, Journal of cataract and refractive surgery.

[26]  J. V. van Gerven,et al.  Cognitive performance and serotonergic function in users of ecstasy , 2000, Psychopharmacology.

[27]  M. Rizzo,et al.  Simulated Car Crashes and Crash Predictors in Drivers With Alzheimer Disease , 1997 .

[28]  M. Rizzo,et al.  Simulated Car Crashes at Intersections in Drivers With Alzheimer Disease , 2001, Alzheimer disease and associated disorders.

[29]  A. Parrott.  Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research , 2001, Human psychopharmacology.

[30]  J. Cadet,et al.  Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms , 2003, Brain Research Reviews.

[31]  J. Fisk,et al.  Working memory deficits in current and previous users of MDMA ('ecstasy'). , 2000, British journal of psychology.

[32]  U. McCann,et al.  (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical Studies , 2000, Neuropsychobiology.

[33]  S. Heishman,et al.  Acute and Residual Effects of Marijuana in Humans , 1998, Pharmacology Biochemistry and Behavior.

[34]  L. Chait.  Subjective and behavioral effects of marijuana the morning after smoking , 2005, Psychopharmacology.

[35]  U. McCann,et al.  Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) users: a controlled study , 1999, Psychopharmacology.

[36]  D. Olton,et al.  3,4-Methylenedioxymethamphetamine, serotonin and memory. , 1993, The Journal of pharmacology and experimental therapeutics.